🗞️ 2048 Ventures Portfolio Company News: Treating Autoimmune Diseases: Four New Technologies To Watch https://t.co/raCg9pAX3u @coding_bio // @2048vc // #startups // #VC
Aiming for Earlier Intervention, Flagship Startup Etiome Emerges to Define ‘Biostages’ of Disease https://t.co/AkGISmvC5B
🦄 Portfolio Company—Pelva Health—Pelva Health closed their $500K pre-seed round, led by Groove, to tackle chronic vulvovaginal pain during intimacy. We're excited to partner with co-founders Kelley & Doug Satoski to restore well-being between partners. https://t.co/ZsCIG7yCKC
Nourish, a virtual nutrition care startup, has raised $70 million in a Series B funding round led by JP Morgan Growth Equity Partners, bringing its valuation above $1 billion. The round included new investors Atomico, G Squared, and PineGrove Venture Partners, along with returning backers Index Ventures, Thrive Capital, Y Combinator, and BoxGroup. Since its founding in 2021, Nourish has raised a total of $115 million. The company was founded by Aidan Dewar, Sam Perkins, and Stephanie Liu. Nourish connects patients with over 3,000 registered dietitians for virtual, insurance-covered nutritional care, and reports that about 95% of its patients receive care fully covered by insurance. The platform has established dozens of partnerships with health plans, employers, health systems, and provider groups, serving hundreds of thousands of patients. Nourish is profitable and has not used its Series A capital. Paris Heymann, co-managing partner at JP Morgan Growth Equity Partners, previously led Nourish's Series A while at Index Ventures. The Series B marks JP Morgan's first digital health investment. The company plans to use the new funds to expand its provider network, hire more dietitians, build out its AI capabilities, and pursue additional strategic partnerships. The Nourish app offers features such as AI-powered meal logging, messaging with care teams, personalized feedback, and meal delivery options. Nourish has launched a GLP-1 companion program and an off-ramp program to support patients using weight-loss drugs like Ozempic. The company claims its GLP-1 patients lose 33% more weight on average than those without its nutrition support. All dietitians are employed as W-2 employees, setting Nourish apart from competitors that use contractors.